Background: Musculoskeletal hydatid cysts are rare, but being locally invasive, can potentially cause significant deformity or pathological fracture.
Background
Among Echinococcus species, E. granulosus and E. multilocularis are commonly reported to be responsible for human hydatidosis. The endemicity of this parasitic infection may vary across countries. Echinococcus larvae develop in cystic form, mostly in the liver or the lungs. The involvement of other organs, and particularly the muscles, is relatively rare. Only 0.5 to 2% of hydatid cysts are skeletally localized [1] .
In this paper we report a rare case of a hydatid cyst located in the soft tissues of the right thigh and involving the proximal femur.
Case presentation
A 39-year-old male was referred by his family physician to our out-patient clinic, complaining of right-sided thigh pain. He had recently moved to our region from Romania (a hyperendemeic area for echinococcosis) and worked as a shepherd.
His previous history included a routine right sided inguinal hernia repair, because of persistent groin pain 9 years previously. As there was no symptomatic improvement after his hernia repair anterior-posterior and lateral radiographs of the affected hip were obtained, showing a cyst in the femoral neck. A few months after the hernia repair, the cyst was explored, curreted and the cavity was bone grafted using corticospongiosus autograft from the iliac crest. The histological examination from the excised tissue showed the presence of Echinococcus granulosus.
The radiographs taken at his recent presentation, 8 years after the previous surgery, showed a multiloculated cyst around a previously implanted cortical screw, which was fixing the bonegraft ( Figure 1 ).
We were aware of the previous histological results which were positive for E. granulosus. Blood tests showed a high serological titer for E. granulosus, but otherwise normal values. To investigate for other potential parasitic sites a CT scan of the brain, skull, chest, abdomen and pelvis was performed, with special attention to the right thigh. The scan confirmed a large (17 × 3 × 5 cm) cyst in the anterolateral part of the proximal thigh within the vastus lateralis ( Figure 2 ). The CT scan is essential in determining the extent of bony disease, especially in the proximal femur. If hip replacement is necessary, the feasibility of using routine implants depends on the destruction of proximal femoral structures, best shown by a CT. If the calcar and/or the greater trochanter have to sacrificed, the surgical plan (implant use, rehabilitation, potential outcome) changes. There were no other cysts visible.
The patient was scheduled for a relatively urgent elective operation, because of the prefracture state and was discharged. Two days prior to the planned procedure, he represented with severe thigh pain, and inability of weight-bearing on the affected side. Subsequent imaging confirmed a non-traumatic pathological fracture in the intertrochanteric region ( Figure 3) . A two step procedure was performed under the same anesthetic, utilizing an extended lateral (Hardinge) approach, with distal extension. During the first part of the procedure an en-bloc excision of the cyst was performed. The lesion was localized between the vastus lateralis and rectus femoris muscles. It had eroded the anterior cortex of the proximal metaphysic, just above the lesser trochanter. After thorough debridement, an adjuvant was used, which is well-established in tumor surgery. The bony bed was exposed to a concentrated phenol solution (70%) via a soaked gauze, followed by copious lavage with a concentrated alcohol solution. No spillage or anaphylaxis was observed during the first part of the procedure.
During the second stage of the procedure, a cemented THR was implanted using an Aesculap implant (Centrament stem, PE-CUP, 28 mm isodur head). The patient received oral Mebendazole (Vermox, Richter Gedeon), 400 mg bid, preoperatively for 5 days. Unlike with intraabdominal pathology, preoperative chemotherapy was only possible for a short period of time, as emergent fracture treatment was necessary. The chemotherapy was continued for 6 weeks postoperatively using the same agent and dose (Mebendazole). The role and length of post-operative adjuvant chemical therapy in musculoskeletal hydatid disease is unclear. In alveolar echinococcosis, it is recommended that chemotherapy is continued for up to 2 years after surgery. The role of life-long chemosuppression is being explored [2] .
Several samples were taken intraoperatively. The histopathological examination confirmed the suspected (Figure 4 and 5). The patient had an uneventful postoperative period, with uncomplicated wound healing. He was asymptomatic at the latest follow-up, one year postoperatively, with a normal plain radiograph ( Figure 6 ). Inflammatory markers are within the normal threshold, however the serological titer remains high (>1024). Patient remains under close (3 monthly) follow-up.
Conclusion
Echinococcosis (or hydatid disease) is a parasitic disease usually infecting mammals (mainly sheep, dogs, rodents and horses). The disease has a worldwide geographical distribution, with clear evidence of the emergence of the condition in parts of eastern Europe [3] . In its adult stage, the parasite resides in the bowels of the animal. The larvae of E. granulosus infect humans, as an intermediate host, giving rise to cystic lesions, which are most frequently found in the liver and the lungs, but very rarely in bone (0.9-2.5%) [4] . The E. granulosus larvae develop via exogenous vesiculation in bones, due to the mechanical stress present. This can eventually lead to mechanical weakening and destruction of the bone trabeculae. The lesions are infiltrative in nature and progress slowly, with the development of numerous microvesicles, but without the parasite encysting. The clinical signs are nonspecific and location-dependent.
In many respects, the disease is reminiscent of chronic osteomyelitis, fibrous dysplasia, osteosarcoma, benign cystic bone lesions, lesions caused by hyperparathyroid tumors and other neoplastic lesions [5] . Due to its prognosis it has been referred to as ''white cancer'' [6] . Standard radiographs usually reveal poorly defined lytic lesions in a classical honeycomb pattern. There is periosteal reaction with localized decalcification [7] . The soft tissue and visceral locations can be explored for abscesses by ultrasonography [7] , whilst CT allows a complete workup of the most lesions. Differential diagnosis can be difficult. An early diagnosis is essential if the affected bone is to be fully eradicated and the healthy tissue salvaged.
In case of bony involvement, the disease has a high recurrence rate of 50%. It however, almost never recurs if the primary lesion is in muscle -0% [8] . If muscles or bones are affected the most commonly used therapeutic regimen is radical surgical excision combined with adjuvant pre-and postoperative chemical therapy. Mebendazole has been the agent of choice historically, for adjuvant chemotherapy. Although no data exists on chemotherapy in musculoskeletal echinococcosis, in patients having intraabdominal pathology, albendazole, especially in combination with praziquantel has proven to be more effective in achieving high serum and cyst fluid levels of albendazole sulphoxide [9] .
Locally aggressive, benign bone tumors require specific techniques to avoid recurrence, thus the experience from their treatment can be used as an analogy for the treatment of musculoskeletal hydatidosis. Surgeons usually perform intralesional curettage, together with some form of adjuvant therapy (the use of intralesional curettage alone can be followed by a recurrence rate of up to 50%). The most commonly applied adjuvant therapies/procedures are cautery, high-speed burring, exothermic cement polymerization and the use of Figure 4 Intraoperative photo of the excised soft tissue lesion after en-bloc surgical excision. certain solutions (e.g. phenol or, more rarely, alcohol) [10, 11] . Capanna et al. reported on a series of 165 benign bone tumors with a high rate of recurrence (e.g. aneurysmal bone cysts, chondroblastomas and giant cell tumors) and noted that the utilization of phenol decreased the local recurrence rate from 41% to 7% [12] .
In our specific case, wide, radical surgical excision of the cyst would have necessitated removal most of the proximal metaphysis, and hence the implantation of a tumorprosthesis.
In view of the patient's age and active life style, we opted to perform an en-bloc excision with a relatively small safe zone, thus sparing both trochanters (with the abductors) and the calcar. To reduce the likelihood of recurrence, 70% phenol solution was used as an adjuvant. The exothermic reaction of cementing can also contribute in preventing recurrence. Using a more limited excision, perhaps carries a higher risk of recurrence. In a young and active patient if the disease recurs, a tumoprosthesis remains a surgical option as a revision procedure. A THR provides a significantly better quality of life in the short term.
The necessary long and extensive surgery carries a higher risk of infection and sepsis, with a substantial risk of death [13] . The use of antibiotic laden antibiotic cement is advisable and might reduce infection risk, therefore we use a pre-mixed dual-combination antibiotic-loaded bone cement (Copal G+C, G = gentamicin, C = clindamycin; Heraeus Medical GmbH, Germany).
In the current English language literature, there are only two cases describing the removal of a primary echinococcus cyst which was eventually followed by successful hip replacement several years later [14, 15] . Replacing the affected hip carries a very high risk for subsequent complications and failure of the implant [16, 17] . Due to the high potential failure rate the patient was informed in detail regarding potential complications and recurrence.
We were unable to find a case report describing a primary echinococcus cyst causing a pathological femoral neck fracture where a single operation was successfully used to treat the cyst and to implant a THR.
Abbreviations THR: Total Hip Replacement.
